Download Duramune® Lyme™+Max 5-CvK/4L

Duramune® Lyme™+Max 5-CvK/4L
(The PuppyShot® Booster+Duramune® Lyme™)
Formerly Duramune® Max 5-CvK/4L+LymeVax®
Description
Duramune Lyme+Max 5-CvK/4L is a canine combination vaccine containing 10 antigens including modified-live distemper,
adenovirus 2, parvovirus 2b, and parainfluenza. It also includes inactivated (killed) coronavirus, Borrelia burgdorferi, and the Leptospira
serovars L. canicola, L. grippotyphosa, L. icterohaemorrhagiae and L. pomona.
Advantages
Features
Benefits
Fewer injections
• Multiple antigens bundled into a single vaccine
• Saves time
• H
elps streamline your vaccine
protocol
• S
pares your patients multiple
injections
• Lower cost compared with the cost of multiple vaccines
Cost effective
Lyme antigen:
• Backed by rigorous field research1-6
• 100 percent preventable fraction in a challenge study
conducted recently for USDA requalification1
• Proven 92 percent effective against natural infection in a
one-of-a-kind study conducted on real-world dogs in a highly
endemic area2 — unprecedented proven efficacy among canine
Lyme vaccines
Proven safety and efficacy1-6
The presence of maternal antibody is
known to interfere with the development
of active immunity. Puppies should be
revaccinated every two to three weeks
until 12 weeks of age.
Indications
For subcutaneous vaccination of healthy
dogs 9 weeks of age or older as an aid
in the prevention of disease caused
by canine distemper, infectious canine
hepatitis, canine adenovirus type 2,
canine coronavirus, canine parainfluenza,
canine parvovirus, Leptospira canicola,
Leptospira icterohaemorrhagiae, Leptospira
grippotyphosa, Leptospira pomona and
Borrelia burgdorferi.
All dogs over 12 weeks of age should initially
receive one dose of this product
and a second dose two to three weeks later.
Annual revaccination with one dose
is recommended.
• S
avings compared with the cost of
multiple vaccines
• G
ives your patients safe, reliable
protection from canine Lyme disease
Product Information
Name
Duramune® Lyme™+Max 5-CvK/4L
(The PuppyShot® Booster+Duramune® Lyme™)
Code
0825E
Size
25 x 1-mL vials of vaccine plus 25 x 1-mL
vials of diluent
Dosage & Administration
Aseptically rehydrate DURAMUNE MAX
5 with canine coronavirus vaccine-Borrelia
burgdorferi bacterin-Leptospira bacterial
extract supplied. SHAKE WELL.
Caution
In case of an anaphylactoid reaction,
administer epinephrine. Burn container
and all unused contents.
Boehringer Ingelheim Vetmedica, Inc.
For healthy dogs 9 weeks of age or older,
administer one 1-mL dose subcutaneously.
Gentamicin and thimerosal added
as preservatives.
Sales Service 1-800-325-9167
Vaccination or revaccination with
this product should begin at or about
9 weeks of age.
For veterinary use only.
www.BI-Vetmedica.com
www.lymeinfo.com
www.leptoinfo.com
Storage Information
Store in the dark at 2º to 7º C (35º to
45º F). AVOID FREEZING.
2621 North Belt Highway
St. Joseph, MO 64506-2002
Information 1-866-638-2226
Fax 1-800-318-8366
USDA Requalification Study, 2007.
1
Levy S. Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted
canine Borrelia burgdorferi infection. Vet Ther. 2002;3(4):420-424.
2
Chu HJ, Chavez LG, Blumer BM, et al. Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin.
JAVMA. 1992;201(3):403-411.
3
Levy SA, Lissman BA, Ficke CM. Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. JAVMA.
1993;202(11):1834-1838.
4
Guerra MA, Walker ED, Kitron J. Quantitative approach for the serodiagnosis of canine Lyme disease by the
immunoblot procedure. J Clin Microbiol. 2000;38(7):2628-2632.
5
Moore GE, Guptill LF, Ward MP, et al. Adverse events diagnosed within three days of
vaccine administration in dogs. JAVMA. 2005;38(7):1102-1108.
6
All trademarks are owned by their manufacturers.
©2010 Boehringer Ingelheim Vetmedica, Inc.
CAN0510005